CPXM1

Across TCGA pan-cancer cohorts, CPXM1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated CPXM1 data layer compared with 26 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CPXM1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CPXM1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

UCEC, LUAD, and PDAC are the cancer types where CPXM1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Quartile	II,III,IV	0.337	1.000	.007	42	view →
LUAD	OS	Median	III,IV	0.220	0.677	.005	16	view →
PDAC	OS	Quartile	All	0.328	0.625	.017	15	view →
LSCC	OS	Median	All	0.918	1.000	.007	5	view →
CCRCC	DFS	Median	III,IV	0.787	0.352	.021	2	view →
HNSC	OS	Tertile	IV	0.581	0.817	.041	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CPXM1–UCEC (DFS)

Open the UCEC breakdown →